Cargando…
Integrative analysis of survival-associated gene sets in breast cancer
BACKGROUND: Patient gene expression information has recently become a clinical feature used to evaluate breast cancer prognosis. The emergence of prognostic gene sets that take advantage of these data has led to a rich library of information that can be used to characterize the molecular nature of a...
Autores principales: | Varn, Frederick S, Ung, Matthew H, Lou, Shao Ke, Cheng, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359519/ https://www.ncbi.nlm.nih.gov/pubmed/25881247 http://dx.doi.org/10.1186/s12920-015-0086-0 |
Ejemplares similares
-
Regulators Associated with Clinical Outcomes Revealed by DNA Methylation Data in Breast Cancer
por: Ung, Matthew H., et al.
Publicado: (2015) -
IDEA: Integrated Drug Expression Analysis—Integration of Gene Expression and Clinical Data for the Identification of Therapeutic Candidates
por: Ung, MH, et al.
Publicado: (2015) -
Application of pharmacologically induced transcriptomic profiles to interrogate PI3K-Akt-mTOR pathway activity associated with cancer patient prognosis
por: Ung, Matthew H., et al.
Publicado: (2016) -
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
por: Mark, Kenneth M. K., et al.
Publicado: (2017) -
Integrative analysis of breast cancer reveals prognostic haematopoietic activity and patient-specific immune response profiles
por: Varn, Frederick S., et al.
Publicado: (2016)